Katie Rush
Family · Prentiss, MSNPI 1891183208
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Ironshore Pharmaceuticals Inc. at 41.0% of the total. Reporting peaked in 2024 at $165 and has fallen 72.1% since, to $46 in 2025. That places this record below the midpoint for family clinicians in MS, where the typical reported total is $371.
Across 25 payments — averaging $14.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$151
- AbbVie$41
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$28
- Mylan Specialty L.p.$21
- Bayer$19
- Sumitomo Pharma America, Inc.$19
- plus $88 from 6 others
What the payments were for
- Food & beverage$368100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 11 | $151 |
| AbbVie | 3 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Mylan Specialty L.p. | 1 | $21 |
| Bayer | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| GSK | 1 | $14 |
| Pfizer | 1 | $14 |
| Abbott | 1 | $12 |
How this compares
$368 in reported general payments places this provider in the 45th percentile of 3,007 family providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $828 |
| Gabapentin | 39 | $425 |
| Mirtazapine | 11 | $347 |
| Potassium Chloride | 19 | $328 |
| ClopidogrelClopidogrel Bisulfate | 31 | $299 |
| Tamsulosin Hcl | 17 | $279 |
| Losartan Potassium | 33 | $259 |
| Rosuvastatin Calcium | 21 | $254 |
| Atorvastatin Calcium | 63 | $229 |
| Levothyroxine Sodium | 27 | $225 |
| Pantoprazole Sodium | 27 | $202 |
| Fluticasone Propionate | 24 | $170 |
| Metoprolol Succinate | 17 | $149 |
| Valsartan | 17 | $148 |
| Sucralfate | 12 | $138 |
Paid to pharmacies, not to this prescriber.
Other family in Prentiss
- Ashley Kirby WarePrentiss$15K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
- Ashley CocilovaFlowood$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.